Dr. Marco Quarta is a scientist, inventor and biotech entrepreneur.
After receiving a doctorate degree in Biotechnology from the University of Bologna (2004) and a Ph.D. in Neuroscience from the University of Padua (2008) he completed a post-doc in Aging and Stem cell Biology in the lab of Prof. Thomas Rando at Stanford University in 2012. He continued his work at Stanford directing a research team at the Center for Tissue Regeneration, Repair, and Restoration at the VA Hospital Palo Alto, where he established a translational program in regenerative medicine. He is author of publications and patents in the field of aging, stem cells, regenerative medicine, and rejuvenation.
He co-founded venture-backed Rubedo Life Sciences with the mission of making a new generation of targeted drugs customized for the elderly to treat the causes of age-related diseases.
Marco also co-founded Wetware Concepts, YEBN, and Turn Biotechnology. He served as an executive board member of the European Federation of Biotechnology. He sits on the advisory board of the California Institute for Regenerative Medicine (CIRM) Calpoly Bridge program, and in the advisory board at the Center for Healthcare Innovation. Marco is a member of the Paul F Glenn Center for the Biology of Aging Studies at Stanford University.
The opinions expressed in interviews or commentary in articles appearing on this site are those of the subject or subjects and do not necessarily reflect the views of LEAF/Lifespan.io, its directors, officers or employees.